Vactech Oy engages in research and development services in the fields of preclinical vaccine development, diagnostics, and biobanking. It develops vaccine technologies for the prevention of human diseases. The firm’s products include vaccines against picornaviruses, which infect human beings and cause common cold, carditis, hepatitis, meningitis, otitis, and paralysis; and enteroviruses that cause severe illnesses. The company was founded by Heikki Antero Hyöty and Mikael Knip in 2001 and is headquartered in Tampere, Finland.

Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ.

Bayer HealthCare Ltd., established on 1995-08-25, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Drug import and export;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;food sales;Health food production;food production;Production of formula food for special medical purpose;Cosmetic production;Production of hygiene products and single-use medical products;Disinfectant production(Free of Hazardous Chemicals).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Cosmetics Wholesale;Cosmetics Retail;internet sales(Except for products that require a license for sale);Food import and export;software development;software sales;Retailing of computer software, hardware and auxiliary equipment;Wholesale of computer software, hardware and auxiliary equipment;Manufacturing of computer software, hardware and peripheral equipment;Software outsourcing service;Information Consulting Service(Not including licensing information consulting services);Information Technology Consulting Services;Special Equipment Repair;Import and export;Technology Import and Export;Import and export agency;Sales of hygiene products and single-use medical products;Disinfectant sales(Free of Hazardous Chemicals);Manufacturing of daily chemical products;Sales of daily chemical products.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Molecular Therapeutics, Inc. (MRx) is a privately held biotechnology holding company that focuses on in-licensing promising pharmaceutical and medical device technologies in the late preclinical development phase and conducts proof-of-principle clinical (phase II) studies on a virtual basis for eventual corporate partnership and commercialization.

Develops and provides biological products for multiplication of primary human cells

Sanofi Pasteur SA develops, manufactures, and supplies vaccines in France and internationally. The company provides vaccines for bacterial and viral diseases, including pertussis, diphtheria, typhoid fever, poliomyelitis, influenza, and mumps. It has production sites in France, the United States, Canada, China, Thailand, and Argentina. The company was formerly known as Aventis Pasteur S.A. and changed its name to Sanofi Pasteur SA in 2004. The company was founded in 1990 and is headquartered in Lyon, France. The company is headquartered in Lyon, France. Sanofi Pasteur SA operates as a subsidiary of Sanofi-Aventis.

Wuhan Boweide Biotechnology Co., Ltd., established on 2010-09-17, Business scope includes biotechnology R&D and development;Bioengineering Information Consulting;Class I medical device,Biological experiment reagents and consumables,scientific research instrument,Wholesale and retail of laboratory reagents.(Projects subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Jilin Shuangzheng Medical Technology Co., Ltd., established on 2013-03-27, Business scope includes biomedical technology research and development and consulting services,technical consulting,technology transfer;medical instruments,Green facilities,computer,Sales and maintenance of printers and consumables;Medical device production;import and export trade(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Fujirebio, Inc. engages in the manufacture, sale, import and export of clinical diagnostic reagents and assay instruments. It also provides diagnostic, clinical laboratory testing and related services. The company was founded on December 18, 1950 and is headquartered in Tokyo, Japan.

Krankenhausbetriebsgesellschaft Bad Oeynhausen mbH provides healthcare services. The company operates through a hospital Herz- und Diabeteszentrum NRW, which treats cardiac, vascular and metabolic diseases. Its main departments include surgery, internal medicine, pediatrics, radiology, nuclear medicine, anaesthesia, laboratory and transfusion medicine and pharmacy. The company is headquartered in Bad Oeynhausen, Germany.

Shenzhen Ai Weidi Biotechnology Co., Ltd., established on 2014-04-10, Business scope includes general business items:Biological product,Technology development of biotechnology products,Operating import and export business;Technical development of diagnostic reagents and raw materials,Technical Services,technology transfer,technical consulting.(None of the above is legal,Administrative regulations,The State Council decides to specify items that require pre-approval and prohibition) ,The licensing program is:Class II,Production of Class III Medical Devices,Sales;Production of diagnostic reagents and raw materials,Sales.

Eli Lilly engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

Hubei Qianjiang Pharmaceutical Co., Ltd. engages in the production of ophthalmic medicines as well as the research and development of related technology and new products. Its products include eye drops, injections, lyophilisates, tablets, capsules, granules, and active pharmaceutical ingredients. The company was founded in 1970 and is headquartered in Qianjiang, China.

Dritte Patentportfolio Beteiligungsgesellschaft mbH & Co. KG is a German private company located in Schoenefeld. The firm provides professional, scientific and technical services. It was founded in 2007.

Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China.

Shanghai Xinwenda Biotechnology Co., Ltd., established on 2001-07-31, Business scope includes general items:Research, development, production and sales of biological fermentation products,biomedicine,Food research and development and related technology development,technical consulting,Technical Services,technology transfer,Business Consulting,Business Management Consulting,Conference and Exhibition Services.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) licensed items:food business(Selling prepackaged food);Food Internet Sales(Selling prepackaged food);Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Hainan Pharmaceutical Factory Co. Ltd. is a private company headquartered in China. The firm engages in manufacturing pharmaceuticals.

Otsuka Holdings operates in pharmaceuticals, nutraceuticals, and consumer products. The business activity of the company includes providing healthcare solutions in the areas of the nervous system, oncology, cardiovascular system, respiratory system, infectious disease, and others. The company engages in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks, and dietary foods.